These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 14967079

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
    Carey J.
    Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112
    [Abstract] [Full Text] [Related]

  • 5. Treatment of Ménière's disease by intratympanic gentamicin application.
    Assimakopoulos D, Patrikakos G.
    J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
    [Abstract] [Full Text] [Related]

  • 6. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A, Aloisi A, De Benedittis G, Scaringi A.
    Ann N Y Acad Sci; 1999 Nov 28; 884():410-24. PubMed ID: 10842610
    [Abstract] [Full Text] [Related]

  • 7. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
    Sam G, Chung DW, van der Hoeven R, Verweij S, Becker M.
    Int J Clin Pharm; 2016 Aug 28; 38(4):780-3. PubMed ID: 27073077
    [Abstract] [Full Text] [Related]

  • 8. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May 28; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 9. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
    Akkuzu B, Ozgirgin N, Ozlüoğlu LN.
    Kulak Burun Bogaz Ihtis Derg; 2006 May 28; 16(5):193-9. PubMed ID: 17124437
    [Abstract] [Full Text] [Related]

  • 10. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB.
    Am J Otol; 1999 Mar 28; 20(2):209-19. PubMed ID: 10100525
    [Abstract] [Full Text] [Related]

  • 11. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ, Fisher LM, Berliner K, Chung J, Green K.
    Otol Neurotol; 2010 Jun 28; 31(4):649-55. PubMed ID: 20431498
    [Abstract] [Full Text] [Related]

  • 12. Intratympanic gentamicin compared with placebo for Ménière's disease.
    de Amesti F, Santander MJ, Winter M.
    Medwave; 2022 Mar 22; 22(2):e8696. PubMed ID: 35323825
    [Abstract] [Full Text] [Related]

  • 13. Low-dose intratympanic gentamicin and the treatment of Meniere's disease: preliminary results.
    Driscoll CL, Kasperbauer JL, Facer GW, Harner SG, Beatty CW.
    Laryngoscope; 1997 Jan 22; 107(1):83-9. PubMed ID: 9001270
    [Abstract] [Full Text] [Related]

  • 14. Intratympanic gentamicin for Menière's disease: a meta-analysis.
    Cohen-Kerem R, Kisilevsky V, Einarson TR, Kozer E, Koren G, Rutka JA.
    Laryngoscope; 2004 Dec 22; 114(12):2085-91. PubMed ID: 15564826
    [Abstract] [Full Text] [Related]

  • 15. Intratympanic gentamicin for treatment of intractable Meniere's disease: a preliminary report.
    Rauch SD, Oas JG.
    Laryngoscope; 1997 Jan 22; 107(1):49-55. PubMed ID: 9001265
    [Abstract] [Full Text] [Related]

  • 16. Intratympanic steroids for Ménière's disease or syndrome.
    Phillips JS, Westerberg B.
    Cochrane Database Syst Rev; 2011 Jul 06; (7):CD008514. PubMed ID: 21735432
    [Abstract] [Full Text] [Related]

  • 17. [Small doses of gentamicin drum indoor injection treatment of intractableMénière disease clinical observation of the impact of the hearing].
    Wang XY.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun 20; 30(12):942-944. PubMed ID: 29771059
    [Abstract] [Full Text] [Related]

  • 18. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
    Pierchała K, Krzeska-Malinowska I, Kowalska M, Bartoszewicz R, Niemczyk K.
    Otolaryngol Pol; 2005 Jun 20; 59(3):409-13. PubMed ID: 16117399
    [Abstract] [Full Text] [Related]

  • 19. Long-Term Follow-Up of Intratympanic Methylprednisolone Versus Gentamicin in Patients With Unilateral Menière's Disease.
    Harcourt JP, Lambert A, Wong PY, Patel M, Agarwal K, Golding JF, Bronstein AM.
    Otol Neurotol; 2019 Apr 20; 40(4):491-496. PubMed ID: 30870364
    [Abstract] [Full Text] [Related]

  • 20. Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis.
    Chia SH, Gamst AC, Anderson JP, Harris JP.
    Otol Neurotol; 2004 Jul 20; 25(4):544-52. PubMed ID: 15241234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.